HHS Says It Won’t Act Against Pharmacies Compounding Six Unapproved Peptides, Against the Advice of FDA Scientists

An interim policy signed by Health Secretary Robert F. Kennedy Jr. says HHS will not act against compounders of BPC-157 and five other peptides. It does not make them FDA approved.
